Metabolic Health Solutions
Search documents
Medifast outlines Q4 2025 revenue guidance of $65M–$80M amid strategic shift to metabolic health solutions (NYSE:MED)
Seeking Alpha· 2025-11-03 23:36
Group 1 - The article does not provide any specific information or data regarding companies or industries [1]
